Quadcap Wealth Management’s AbbVie ABBV Stock Holding History

Quadcap Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.6M	Sell	11,966 -45	-0.4%	-$9.98K	0.3%	75
2025 Q4	$2.74M	Sell	12,011 -33	-0.3%	-$7.52K	0.31%	69
2025 Q3	$2.79M	Sell	12,044 -21	-0.2%	-$4.28K	0.33%	67
2025 Q2	$2.24M	Sell	12,065 -102	-0.8%	-$19K	0.28%	69
2025 Q1	$2.55M	Buy	12,167 +154	+1%	+$29.9K	0.37%	58
2024 Q4	$2.13M	Sell	12,013 -376	-3%	-$69.1K	0.31%	65
2024 Q3	$2.45M	Buy	12,389 +1,357	+12%	+$253K	0.38%	55
2024 Q2	$1.89M	Buy	11,032 +436	+4%	+$72.2K	0.34%	63
2024 Q1	$1.93M	Sell	10,596 -354	-3%	-$61K	0.44%	49
2023 Q4	$1.7M	Buy	+10,950	New	+$1.6M	0.44%	57

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quadcap Wealth Management's ABBV Position: Q1 2026 in Review

Quadcap Wealth Management reduced its AbbVie (ABBV) stake by 0.37% in Q1 2026, selling an estimated $9.98K and leaving 11,966 shares worth $2.6M. The position accounts for 0.3% of the portfolio, ranked #75.

Quadcap Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.79M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Quadcap Wealth Management held 11,966 shares of AbbVie worth $2.6M as of Q1 2026.
Quadcap Wealth Management sold 45 AbbVie shares in Q1 2026, an estimated $9.98K.
AbbVie made up 0.3% of Quadcap Wealth Management's portfolio in Q1 2026, its #75 holding.
Quadcap Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Quadcap Wealth Management's AbbVie position peaked at $2.79M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Quadcap Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.